Psychedelic Research Bulletin: December 2021

Nova Mentis Provides Corporate Update – 2022 Planned Catalysts

Filament Health and Cybin Therapeutics Announce Licensing Agreement

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

Psychedelic Bulletin: MindMed Co-Founder Resigns from Board; Global Coalition to Reschedule...

Numinus Submits Clinical Trial Application for Phase 1 Trial on Proprietary...

PharmaDrug Announces Resignation of Director

PT284 – Jonathan Sabbagh – Ketamine-Assisted Psychotherapy and Collaborative Care

Mydecine to Launch Special Access Support and Supply Program in Canada...

MYND Life Sciences Announces Collaborative Research Agreement with the University of...

Load more